These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 10940298
1. c-Cbl is a suppressor of the neu oncogene. Levkowitz G, Oved S, Klapper LN, Harari D, Lavi S, Sela M, Yarden Y. J Biol Chem; 2000 Nov 10; 275(45):35532-9. PubMed ID: 10940298 [Abstract] [Full Text] [Related]
2. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation. Bowtell DD, Langdon WY. Oncogene; 1995 Oct 19; 11(8):1561-7. PubMed ID: 7478580 [Abstract] [Full Text] [Related]
3. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Dankort D, Maslikowski B, Warner N, Kanno N, Kim H, Wang Z, Moran MF, Oshima RG, Cardiff RD, Muller WJ. Mol Cell Biol; 2001 Mar 19; 21(5):1540-51. PubMed ID: 11238891 [Abstract] [Full Text] [Related]
4. Cbl functions downstream of Src kinases in Fc gamma RI signaling in primary human macrophages. Erdreich-Epstein A, Liu M, Kant AM, Izadi KD, Nolta JA, Durden DL. J Leukoc Biol; 1999 Apr 19; 65(4):523-34. PubMed ID: 10204582 [Abstract] [Full Text] [Related]
5. The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing. Waterman H, Alroy I, Strano S, Seger R, Yarden Y. EMBO J; 1999 Jun 15; 18(12):3348-58. PubMed ID: 10369675 [Abstract] [Full Text] [Related]
6. CD16-mediated activation of phosphatidylinositol-3 kinase (PI-3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb2, Shc, pp36 and p85 PI-3K subunit. Cerboni C, Gismondi A, Palmieri G, Piccoli M, Frati L, Santoni A. Eur J Immunol; 1998 Mar 15; 28(3):1005-15. PubMed ID: 9541596 [Abstract] [Full Text] [Related]
7. CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. Szymkiewicz I, Kowanetz K, Soubeyran P, Dinarina A, Lipkowitz S, Dikic I. J Biol Chem; 2002 Oct 18; 277(42):39666-72. PubMed ID: 12177062 [Abstract] [Full Text] [Related]
8. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells. Sattler M, Pride YB, Quinnan LR, Verma S, Malouf NA, Husson H, Salgia R, Lipkowitz S, Griffin JD. Oncogene; 2002 Feb 21; 21(9):1423-33. PubMed ID: 11857085 [Abstract] [Full Text] [Related]
9. The roles of Cbl-b and c-Cbl in insulin-stimulated glucose transport. Liu J, DeYoung SM, Hwang JB, O'Leary EE, Saltiel AR. J Biol Chem; 2003 Sep 19; 278(38):36754-62. PubMed ID: 12842890 [Abstract] [Full Text] [Related]
10. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells. Hennige AM, Lammers R, Arlt D, Höppner W, Strack V, Niederfellner G, Seif FJ, Häring HU, Kellerer M. Mol Cell Endocrinol; 2000 Sep 25; 167(1-2):69-76. PubMed ID: 11000521 [Abstract] [Full Text] [Related]
11. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. Besset V, Scott RP, Ibáñez CF. J Biol Chem; 2000 Dec 15; 275(50):39159-66. PubMed ID: 10995764 [Abstract] [Full Text] [Related]
12. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase. Park RK, Erdreich-Epstein A, Liu M, Izadi KD, Durden DL. J Immunol; 1999 Dec 01; 163(11):6023-34. PubMed ID: 10570290 [Abstract] [Full Text] [Related]
13. c-Cbl is inducibly tyrosine-phosphorylated by epidermal growth factor stimulation in fibroblasts, and constitutively tyrosine-phosphorylated and associated with v-Src in v-src-transformed fibroblasts. Odai H, Sasaki K, Hanazono Y, Ueno H, Tanaka T, Miyagawa K, Mitani K, Yazaki Y, Hirai H. Jpn J Cancer Res; 1995 Dec 01; 86(12):1119-26. PubMed ID: 8635998 [Abstract] [Full Text] [Related]
14. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. Kaabeche K, Lemonnier J, Le Mée S, Caverzasio J, Marie PJ. J Biol Chem; 2004 Aug 27; 279(35):36259-67. PubMed ID: 15190072 [Abstract] [Full Text] [Related]
15. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl. Thien CB, Langdon WY. Oncogene; 1997 Dec 11; 15(24):2909-19. PubMed ID: 9416834 [Abstract] [Full Text] [Related]
16. An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex. McManus MJ, Boerner JL, Danielsen AJ, Wang Z, Matsumura F, Maihle NJ. J Biol Chem; 2000 Nov 10; 275(45):35328-34. PubMed ID: 10954714 [Abstract] [Full Text] [Related]
17. Involvement of Shc and Cbl-PI 3-kinase in Lyn-dependent proliferative signaling pathways for G-CSF. Grishin A, Sinha S, Roginskaya V, Boyer MJ, Gomez-Cambronero J, Zuo S, Kurosaki T, Romero G, Corey SJ. Oncogene; 2000 Jan 06; 19(1):97-105. PubMed ID: 10644984 [Abstract] [Full Text] [Related]
18. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination. Taher TE, Tjin EP, Beuling EA, Borst J, Spaargaren M, Pals ST. J Immunol; 2002 Oct 01; 169(7):3793-800. PubMed ID: 12244174 [Abstract] [Full Text] [Related]
19. FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates. Lavagna-Sévenier C, Marchetto S, Birnbaum D, Rosnet O. Leukemia; 1998 Mar 01; 12(3):301-10. PubMed ID: 9529123 [Abstract] [Full Text] [Related]
20. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase. Jain SK, Langdon WY, Varticovski L. Oncogene; 1997 May 08; 14(18):2217-28. PubMed ID: 9174058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]